No data to show
OTCM
CYBQY
Market cap169mUSD
Jul 11, Last price
1.12USD
1D
0.00%
1Q
5.11%
IPO
-91.58%
Name
Cyberdyne Inc
Chart & Performance
P/E
—
P/S
5.06
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-0.37%
Rev. gr., 5y
20.57%
Revenues
4.35b
+32.38%
Net income
-1.48b
L+395.30%
CFO
-850m
L+494.41%
Earnings
Aug 12, 2025
Profile
CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains equipment and systems for medical and warfare in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use in lower limb and single joint type; non-medical HAL for lower limb, single joint type, and lumbar type; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; and Acoustic X, a high speed light pulse LED array light source that enables real time photoacoustic imaging. It also provides Cybernics Treatment, a treatment that uses HAL to enhance/regenerate the function of the wearer for spinal cord injury, stroke, neuromuscular diseases, etc.; HAL FIT for enhancement of brain-nerve-musculoskeltal system; MTX Neuro HAL Plus to enhance the performance of the athletes' brain-nerve functions; and Neuro HALFIT for enhancement of physical functions. In addition, the company is involved in the provision of rescue supports in disaster sites, and heavy labor supports for factories and plants; and entertainment business. The company was incorporated in 2004 and is headquartered in Tsukuba, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | |
| Income | |||||||||
Revenues | 4,354,000 32.38% | 3,289,000 52.98% | |||||||
Cost of revenue | 6,089,000 | 4,910,000 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (1,735,000) | (1,621,000) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | 507,000 | 446,000 | |||||||
Tax Rate | |||||||||
NOPAT | (2,242,000) | (2,067,000) | |||||||
Net income | (1,476,000) 395.30% | (298,000) -39.43% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | (1,188,000) | ||||||||
BB yield | 1.95% | ||||||||
| Debt | |||||||||
Debt current | 244,000 | 236,000 | |||||||
Long-term debt | 914,000 | 992,000 | |||||||
Deferred revenue | 96,000 | ||||||||
Other long-term liabilities | 5,858,000 | 4,807,000 | |||||||
Net debt | (19,072,000) | (30,127,000) | |||||||
| Cash flow | |||||||||
Cash from operating activities | (850,000) | (143,000) | |||||||
CAPEX | (216,000) | (509,000) | |||||||
Cash from investing activities | (2,075,000) | 2,173,000 | |||||||
Cash from financing activities | 160,000 | 14,000 | |||||||
FCF | (13,479,000) | (1,527,000) | |||||||
| Balance | |||||||||
Cash | 5,155,000 | 17,308,000 | |||||||
Long term investments | 15,075,000 | 14,047,000 | |||||||
Excess cash | 20,012,300 | 31,190,550 | |||||||
Stockholders' equity | (360,000) | 43,374,000 | |||||||
Invested Capital | 47,327,000 | 16,364,450 | |||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | 211,131 | 214,707 | |||||||
Price | 213.00 -25.00% | 284.00 -21.98% | |||||||
Market cap | 44,970,953 -26.25% | 60,976,714 -22.13% | |||||||
EV | 25,623,953 | 73,811,714 | |||||||
EBITDA | (1,058,000) | (994,000) | |||||||
EV/EBITDA | |||||||||
Interest | 482,000 | 193,000 | |||||||
Interest/NOPBT | |||||||||